Skip to main content
Top
Published in: Indian Journal of Pediatrics 9/2014

01-09-2014 | Clinical Brief

Ifosfamide Induced Renal Rickets

Authors: Arul P. Lionel, Girish Chinnaswamy, Rikki R. John, Sarah Mathai

Published in: Indian Journal of Pediatrics | Issue 9/2014

Login to get access

Abstract

Ifosfamide is commonly used as a chemotherapeutic agent in children. The authors report a 4-y-old boy who developed proximal renal tubulopathy with florid rickets a year after completion of ifosfamide therapy for Ewing's sarcoma. After initiation of treatment, there was complete healing of rickets and he did not need supplements beyond 18 mo. Growth monitoring and musculoskeletal system examination is important in all children who have received ifosfamide therapy. Routine monitoring for nephrotoxicity during and after ifosfamide therapy helps in early identification and intervention.
Literature
2.
go back to reference Springate JE. Ifosfamide metabolite chloroacetaldehyde causes renal dysfunction in vivo. J Appl Toxicol. 1997;17:75–9.PubMedCrossRef Springate JE. Ifosfamide metabolite chloroacetaldehyde causes renal dysfunction in vivo. J Appl Toxicol. 1997;17:75–9.PubMedCrossRef
3.
4.
go back to reference Stöhr W, Paulides M, Bielack S, Jürgens H, Treuner J, Rossi R, et al. Ifosfamide-induced nephrotoxicity in 593 sarcoma patients: A report from the late effects surveillance system. Pediatr Blood Cancer. 2007;48:447–52.PubMedCrossRef Stöhr W, Paulides M, Bielack S, Jürgens H, Treuner J, Rossi R, et al. Ifosfamide-induced nephrotoxicity in 593 sarcoma patients: A report from the late effects surveillance system. Pediatr Blood Cancer. 2007;48:447–52.PubMedCrossRef
5.
go back to reference Oberlin O, Fawaz O, Rey A, Niaudet P, Ridola V, Orbach D, et al. Long-term evaluation of ifosfamide-related nephrotoxicity in children. J Clin Oncol. 2009;27:5350–5.PubMedCrossRef Oberlin O, Fawaz O, Rey A, Niaudet P, Ridola V, Orbach D, et al. Long-term evaluation of ifosfamide-related nephrotoxicity in children. J Clin Oncol. 2009;27:5350–5.PubMedCrossRef
6.
go back to reference Skinner R, Cotterill SJ, Stevens MC. Risk factors for nephrotoxicity after ifosfamide treatment in children: A UKCCSG late effects group study. United Kingdom children’s cancer study group. Br J Cancer. 2000;82:1636–45.PubMedCentralPubMedCrossRef Skinner R, Cotterill SJ, Stevens MC. Risk factors for nephrotoxicity after ifosfamide treatment in children: A UKCCSG late effects group study. United Kingdom children’s cancer study group. Br J Cancer. 2000;82:1636–45.PubMedCentralPubMedCrossRef
7.
go back to reference McCune JS, Risler LJ, Phillips BR, Thummel KE, Blough D, Shen DD. Contribution of CYP3A5 to hepatic and renal ifosfamide N-dechloroethylation. Drug Metab Dispos. 2005;33:1074–81.PubMedCrossRef McCune JS, Risler LJ, Phillips BR, Thummel KE, Blough D, Shen DD. Contribution of CYP3A5 to hepatic and renal ifosfamide N-dechloroethylation. Drug Metab Dispos. 2005;33:1074–81.PubMedCrossRef
8.
go back to reference Rossi R, Pleyer J, Schafers P, Schäfers P, Kuhn N, Kleta R, et al. Development of ifosfamide induced nephrotoxicity: Prospective follow-up in 75 patients. Med Pediatr Oncol. 1999;32:177–82.PubMedCrossRef Rossi R, Pleyer J, Schafers P, Schäfers P, Kuhn N, Kleta R, et al. Development of ifosfamide induced nephrotoxicity: Prospective follow-up in 75 patients. Med Pediatr Oncol. 1999;32:177–82.PubMedCrossRef
9.
go back to reference Skinner R, Parry A, Price L, Cole M, Craft AW, Pearson AD. Glomerular toxicity persists 10 y after ifosfamide treatment in childhood and is not predictable by age or dose. Pediatr Blood Cancer. 2010;54:983–9.PubMedCrossRef Skinner R, Parry A, Price L, Cole M, Craft AW, Pearson AD. Glomerular toxicity persists 10 y after ifosfamide treatment in childhood and is not predictable by age or dose. Pediatr Blood Cancer. 2010;54:983–9.PubMedCrossRef
Metadata
Title
Ifosfamide Induced Renal Rickets
Authors
Arul P. Lionel
Girish Chinnaswamy
Rikki R. John
Sarah Mathai
Publication date
01-09-2014
Publisher
Springer India
Published in
Indian Journal of Pediatrics / Issue 9/2014
Print ISSN: 0019-5456
Electronic ISSN: 0973-7693
DOI
https://doi.org/10.1007/s12098-013-1112-x

Other articles of this Issue 9/2014

Indian Journal of Pediatrics 9/2014 Go to the issue